iPAWS: Improving Pain Management After Wisdom Tooth Extraction Surgery
for Pain, Postoperative
1 location in Providence
Sponsor: Brown University
Sex: All·Age: 15 - 20·Accepts healthy volunteers
Code: NCT07731295·Recruiting·Listed Jul 28, 2026
Paid Clinical Trials in Rhode Island
Rhode Island has 486 paid clinical trials enrolling now across cities including Providence, Westerly and East Providence. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Rhode Island include Brown University, National Cancer Institute (NCI) and Rhode Island Hospital, running studies across oncology, cardiology, neurology, and more. The most actively recruiting conditions are Advanced Solid Tumor, Obesity, Ulcerative Colitis, Crohn's Disease — browse the full list or use the filters to match your diagnosis. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Rhode Island
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training
for Alcohol Use Disorder
1 location in Providence
Sponsor: Brown University
Sex: All·Age: 13 - 19·Accepts healthy volunteers
Code: NCT07713251·Recruiting·Listed Jul 20, 2026
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
for Weight Management
Sites in East Providence +54 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07667803·Phase 3·Recruiting·Listed Jun 25, 2026
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
for Alcohol Drinking
1 location in Providence
Sponsor: Brown University
Sex: All·Age: 18 - 25·Accepts healthy volunteers
Code: NCT07663448·Recruiting·Listed Jun 23, 2026
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
for Type 2 Diabetes Mellitus
Drug: Dapagliflozin
Sites in East Providence +27 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07662135·Phase 3·Recruiting·Listed Jun 23, 2026
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
for Obesity
Drug: NNC0662-0419
Sites in Cumberland +23 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07639021·Phase 2·Recruiting·Listed Jun 10, 2026
444 clinical trials
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
for Obesity
Drug: Semaglutide
Sites in Cumberland +98 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07564414·Phase 3·Recruiting·Listed May 2026
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
for Type 2 Diabetes
Sites in East Greenwich +24 more locations
Sponsor: Housey Healthcare ULC
Sex: All·Age: 18+
Code: NCT07546929·Phase 2·Recruiting·Listed Apr 2026
A Study of Brenipatide in Participants With Opioid Use Disorder
for Opioid Use Disorder
Drug: Brenipatide
Sites in Providence +37 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07420283·Phase 2·Recruiting·Listed Feb 2026
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for Pancreatic Cancer
Sites in Providence +38 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT07409272·Phase 3·Recruiting·Listed Feb 2026
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for Diabetic Peripheral Neuropathic Pain
Sites in East Greenwich +69 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 18 - 80
Code: NCT07231419·Phase 3·Recruiting·Listed Nov 2025
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
for Atopic Dermatitis
Sites in Warwick +42 more locations
Sponsor: Sanofi
Sex: All·Age: 12+
Code: NCT07290803·Recruiting·Listed Dec 2025
Study of DONQ52 in Active Celiac Disease
for Celiac Disease
Drug: DONQ52
Sites in Providence +54 more locations
Sponsor: Chugai Pharmaceutical
Sex: All·Age: 18 - 75
Code: NCT07239336·Phase 2·Recruiting·Listed Nov 2025
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
for Obesity
Drug: Semaglutide
Sites in East Greenwich +26 more locations
Sponsor: Kailera
Sex: All·Age: 18+
Code: NCT07284979·Phase 3·Recruiting·Listed Dec 2025
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for Focal Segmental Glomerulosclerosis
Sites in East Providence +65 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 12+
Code: NCT07220083·Phase 3·Recruiting·Listed Oct 2025
A Study of Brenipatide in Participants With Alcohol Use Disorder
for Alcohol Use Disorder
Drug: Brenipatide
Sites in Providence +28 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219953·Phase 3·Recruiting·Listed Oct 2025
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
for Metabolic Dysfunction-Associated Steatotic Liver Disease
Sites in Providence +140 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07165028·Phase 3·Recruiting·Listed Sep 2025
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for Ovarian Neoplasms
Sites in Providence +87 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07213804·Phase 3·Recruiting·Listed Oct 2025
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for Alzheimers Disease
Sites in Providence +67 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07177352·Phase 3·Recruiting·Listed Sep 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
Drug: Duvakitug
Sites in Providence +93 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for Ulcerative Colitis
Drug: LY4268989
Sites in Providence +39 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07186101·Phase 2·Recruiting·Listed Sep 2025
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
Drug: Olpasiran
Sites in East Greenwich +200 more locations
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for Crohn Disease
Sites in Providence +54 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07196722·Phase 2, Phase 3·Recruiting·Listed Sep 2025
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
for Colitis, Ulcerative
Sites in Providence +50 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 12+
Code: NCT07196748·Phase 3·Recruiting·Listed Sep 2025
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for Metastatic Colorectal Cancer (CRC)
Drug: Bevacizumab
Sites in Providence +82 more locations
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT07228832·Phase 3·Recruiting·Listed Nov 2025
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
for Respiratory Syncytial Virus Infections
Sites in Providence +34 more locations
Sponsor: Shionogi
Sex: All·Age: 18+
Code: NCT07214571·Phase 2·Recruiting·Listed Oct 2025
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
for Alzheimers Disease
Drug: Trontinemab
Sites in Providence +34 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07169578·Phase 3·Recruiting·Listed Sep 2025
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
for Atherosclerotic Cardiovascular Disease
Sites in East Greenwich +137 more locations
Sponsor: Amgen
Sex: All·Age: 45 - 99
Code: NCT07037433·Phase 3·Recruiting·Listed Jun 2025
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for Melanoma
Sites in Providence +89 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for Triple Negative Breast Cancer
Sites in Providence +123 more locations
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for Breast Cancer
Sites in Providence +168 more locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for Pediatric Migraine
Sites in East Greenwich +80 more locations
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04649242·Phase 3·Recruiting·Listed Dec 2020
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
for Cervical Cancer
Sites in Providence +127 more locations
Sponsor: Pfizer
Sex: Female·Age: 18+
Code: NCT06952660·Phase 4·Recruiting·Listed May 2025
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for End Stage Kidney Disease
Drug: Clazakizumab
Sites in East Providence +146 more locations
Sponsor: CSL Behring
Sex: All·Age: 18+
Code: NCT05485961·Phase 2, Phase 3·Recruiting·Listed Aug 2022
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for Proteinuric Kidney Disease
Sites in East Providence +166 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 10 - 65
Code: NCT05312879·Phase 2, Phase 3·Recruiting·Listed Apr 2022
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for Acute Treatment of Migraine
Drug: Rimegepant
Sites in East Greenwich +61 more locations
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04743141·Phase 3·Recruiting·Listed Feb 2021
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for Multiple Myeloma
Drug: Elranatamab
Sites in Providence +94 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT06152575·Phase 3·Recruiting·Listed Nov 2023
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for Early Breast Cancer
Drug: Ribociclib
Sites in Providence +84 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT05827081·Phase 3·Recruiting·Listed Apr 2023
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
Drug: Duvakitug
Sites in Providence +90 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184996·Phase 3·Recruiting·Listed Sep 2025
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for Diabetic Peripheral Neuropathic Pain
Sites in East Greenwich +58 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 18 - 80
Code: NCT06628908·Phase 3·Recruiting·Listed Oct 2024
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Providence +87 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for Crohn's Disease
Drug: Tulisokibart
Sites in Providence +70 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 16 - 80
Code: NCT06430801·Phase 3·Recruiting·Listed May 2024
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Drug: Giredestrant
Sites in Providence +53 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06065748·Phase 3·Recruiting·Listed Oct 2023
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
for Ulcerative Colitis
Sites in Providence +77 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 80
Code: NCT06581328·Phase 4·Recruiting·Listed Sep 2024
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for Endometrial Cancer
Sites in Providence +45 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: Female·Age: 18+
Code: NCT06952504·Phase 3·Recruiting·Listed May 2025
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Warwick +2342 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Common conditions studied in Rhode Island
- Advanced Solid Tumor (10 active studies)
- Obesity (9 active studies)
- Ulcerative Colitis (9 active studies)
- Crohn's Disease (8 active studies)
- Endometrial Cancer (8 active studies)
- Acute Myeloid Leukemia (7 active studies)
Leading research sponsors in Rhode Island
- Brown University
- National Cancer Institute (NCI)
- Rhode Island Hospital
- AstraZeneca
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Rhode Island?
There are approximately 486 recruiting clinical trials in Rhode Island listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Rhode Island pay participants?
Most recruiting trials in Rhode Island compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Rhode Island?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Rhode Island?
The most common conditions under active study in Rhode Island include Advanced Solid Tumor (10), Obesity (9), Ulcerative Colitis (9), Crohn's Disease (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Rhode Island?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Rhode Island on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Rhode Island?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.